Pre-clinical models of small cell lung cancer and the validation of therapeutic targets
- 26 February 2020
- journal article
- review article
- Published by Taylor & Francis Ltd in Emerging Therapeutic Targets
- Vol. 24 (3), 187-204
- https://doi.org/10.1080/14728222.2020.1732353
Abstract
Introduction Small cell lung cancer (SCLC) is an aggressive form of lung cancer which has a dismal prognosis. One of the factors hindering therapeutic developments for SCLC is that most SCLC is not surgically resected resulting in a paucity of material for analysis. To address this, significant efforts have been made by investigators to develop pre-clinical models of SCLC allowing for downstream target identification in this difficult to treat cancer. Areas Covered In this review we describe the current pre-clinical models that have been developed to interrogate SCLC, and outline the benefits and limitations associated with each. Using examples we show how each has been used to (i) improve our knowledge of this intractable cancer, and (ii) identify and validate potential therapeutic targets that (iii) are currently under development and testing within the clinic. Expert Opinion The large numbers of pre-clinical models that have been developed have dramatically improved the ways in which we can examine SCLC and test therapeutic targets/interventions. The newer models are rapidly providing novel avenues for the design and testing of new therapeutics. Despite this many of these models have inherent flaws which limit the possibility of their use for individualized therapy decision making for SCLC.Keywords
This publication has 170 references indexed in Scilit:
- Litopenaeus vannamei Sterile-Alpha and Armadillo Motif Containing Protein (LvSARM) Is Involved in Regulation of Penaeidins and antilipopolysaccharide factorsPLOS ONE, 2013
- DNA Methylation Screening Identifies Driver Epigenetic Events of Cancer Cell SurvivalCancer Cell, 2012
- HIF-1α effects on angiogenic potential in human small cell lung carcinomaJournal of Experimental & Clinical Cancer Research, 2011
- Nuclear factor I/B is an oncogene in small cell lung cancerPublished by Cold Spring Harbor Laboratory ,2011
- Lung cancer cell lines: Useless artifacts or invaluable tools for medical science?Lung Cancer, 2010
- Loss of p130 Accelerates Tumor Development in a Mouse Model for Human Small-Cell Lung CarcinomaCancer Research, 2010
- A Primary Xenograft Model of Small-Cell Lung Cancer Reveals Irreversible Changes in Gene Expression Imposed by CultureIn vitroCancer Research, 2009
- Mouse xenograft models vs GEM models for human cancer therapeuticsDisease Models & Mechanisms, 2008
- CD56: a useful tool for the diagnosis of small cell lung carcinomas on biopsies with extensive crush artefactJournal of Clinical Pathology, 2005
- Intratumoral phenotypic diversity of cloned human lung tumor cell lines and consequences for analyses with monoclonal antibodiesCancer, 1984